ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $104,000 | -86.2% | 103,500 | -86.2% | 0.00% | – |
Q2 2021 | $756,000 | -16.6% | 752,500 | -15.8% | 0.00% | – |
Q1 2021 | $906,000 | -11.1% | 893,500 | -5.3% | 0.00% | – |
Q4 2020 | $1,019,000 | -2.1% | 943,500 | -6.4% | 0.00% | – |
Q3 2020 | $1,041,000 | -11.3% | 1,007,500 | -5.3% | 0.00% | – |
Q2 2020 | $1,173,000 | +6.5% | 1,064,000 | -2.2% | 0.00% | – |
Q1 2020 | $1,101,000 | -58.0% | 1,088,000 | -52.6% | 0.00% | -100.0% |
Q4 2019 | $2,624,000 | -69.7% | 2,293,000 | -69.8% | 0.00% | -50.0% |
Q3 2019 | $8,653,000 | +167.0% | 7,587,000 | +176.9% | 0.00% | +100.0% |
Q2 2019 | $3,241,000 | -61.7% | 2,740,000 | -56.3% | 0.00% | -66.7% |
Q1 2019 | $8,467,000 | +488.8% | 6,264,000 | +366.1% | 0.00% | – |
Q4 2018 | $1,438,000 | -0.1% | 1,344,000 | -2.0% | 0.00% | – |
Q3 2018 | $1,440,000 | -70.5% | 1,372,000 | -72.4% | 0.00% | -100.0% |
Q2 2018 | $4,885,000 | -63.4% | 4,972,000 | -63.2% | 0.00% | -75.0% |
Q1 2018 | $13,347,000 | +207.6% | 13,510,000 | +228.7% | 0.00% | +300.0% |
Q4 2017 | $4,339,000 | -8.5% | 4,110,000 | -8.4% | 0.00% | 0.0% |
Q3 2017 | $4,740,000 | -62.5% | 4,487,000 | -62.4% | 0.00% | -75.0% |
Q2 2017 | $12,653,000 | +6.0% | 11,930,000 | -3.7% | 0.00% | 0.0% |
Q1 2017 | $11,933,000 | +547.8% | 12,390,000 | +580.4% | 0.00% | +300.0% |
Q4 2016 | $1,842,000 | +1969.7% | 1,821,000 | +1777.3% | 0.00% | – |
Q3 2016 | $89,000 | -98.9% | 97,000 | -99.2% | 0.00% | -100.0% |
Q2 2016 | $8,141,000 | +171.5% | 11,468,000 | +245.6% | 0.00% | +200.0% |
Q1 2016 | $2,999,000 | -33.7% | 3,318,000 | -17.0% | 0.00% | -50.0% |
Q4 2015 | $4,522,000 | – | 4,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|